2021-03-31-accounts - Evolve - Tackling the Impact of Substance Misuse

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Report of the Director and

Unaudited Financial Statements for the Year Ended 31 March 2021

for

Evolve

Tackling The Impact Of Substance Misuse

Evolve Tackling The Impact Of Substance Misuse

Contents of the Financial Statements for the Year Ended 31 March 2021

	Page
Company Information	1
Report of the Director	2
Income Statement	3
Balance Sheet	4
Notes to the Financial Statements	5
Detailed Income and Expenditure Account	7

Evolve Tackling The Impact Of Substance Misuse

Company Information for the Year Ended 31 March 2021

REGISTERED OFFICE: c/o Beaconsfield Community House Rock Ferry Wirral CH42 3YN REGISTERED NUMBER: 1153938 (England and Wales) ACCOUNTANTS: LJS Accounting Services (UK) Ltd Unit 5, 1st Floor Connect Business Village 24 Derby Road Liverpool Merseyside L5 9PR

Page 1

Evolve

Tackling The Impact Of Substance Misuse

Report of the Director

for the Year Ended 31 March 2021

The director presents report with the financial statements of the company for the year ended 31 March 2021.

DIRECTOR

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:

........................................................................ Director 25/11/2021 Date: .............................................

Page 2

Evolve

Tackling The Impact Of Substance Misuse

Income Statement

for the Year Ended 31 March 2021

		31.3.21	31.3.20
	Notes	£	£
TURNOVER		16,499	35,363
Cost of sales		-	320
GROSS SURPLUS		16,499	35,043
Administrative expenses		42,925	47,535
		(26,426)	(12,492)
Other operating income		31,248	-
OPERATING SURPLUS/(DEFICIT) and
SURPLUS/(DEFICIT) BEFORE
TAXATION		4,822	(12,492)
Tax on surplus/(deficit)		-	-
SURPLUS/(DEFICIT) FOR THE
FINANCIAL YEAR		4,822	(12,492)

The notes form part of these financial statements

Page 3

Evolve

Tackling The Impact Of Substance Misuse (Registered number: 1153938)

Balance Sheet

31 March 2021

Notes FIXED ASSETS Tangible assets 5 CURRENT ASSETS Cash at bank CREDITORS Amounts falling due within one year 6 NET CURRENT ASSETS TOTAL ASSETS LESS CURRENT LIABILITIES RESERVES Income and expenditure account 7	31.3.21 £ 15,452 668	£ 210 14,784 14,994 14,994 14,994	31.3.20 £ 11,303 1,446	£ 315 9,857
				10,172
				10,172
				10,172

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges

responsibilities for:

(a) ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on ............................................. and were signed by: 25/11/2021

........................................................................ Director

The notes form part of these financial statements

Page 4

Evolve Tackling The Impact Of Substance Misuse

Notes to the Financial Statements for the Year Ended 31 March 2021

1. STATUTORY INFORMATION

Evolve Tackling The Impact Of Substance Misuse is a private company, limited by guarantee, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. Fixtures and fittings - at varying rates on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2020 - 2).

Page 5

continued...

Evolve Tackling The Impact Of Substance Misuse

Notes to the Financial Statements - continued for the Year Ended 31 March 2021

4. OPERATING SURPLUS/(DEFICIT)

The operating surplus (2020 - operating deficit) is stated after charging:

		31.3.21	31.3.20
		£	£
	Depreciation - owned assets	105	-
5.	TANGIBLE FIXED ASSETS
			Fixtures
			and
			fittings
			£
	COST
	At 1 April 2020
	and 31 March 2021		630
	DEPRECIATION
	At 1 April 2020		315
	Charge for year		105
	At 31 March 2021		420
	NET BOOK VALUE
	At 31 March 2021		210
	At 31 March 2020		315
6.	CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
		31.3.21	31.3.20
		£	£
	Social security and other taxes	668	696
	Accrued expenses	-	750
		668	1,446
7.	RESERVES
			Income
			and
			expenditure
			account
			£
	At 1 April 2020		10,172
	Surplus for the year		4,822
	At 31 March 2021		14,994

Page 6

Evolve

Tackling The Impact Of Substance Misuse

Detailed Income and Expenditure Account for the Year Ended 31 March 2021

Turnover Unrestricted Funds Restricted Funds Donations Cost of sales Purchases GROSS SURPLUS Other income Government grants Expenditure Insurance Wages Social security Pensions Post and stationery Advertising Travel and subsistence Computer costs Training Subscriptions Depreciation of tangible fixed assets Fixtures and fittings NET SURPLUS/(DEFICIT)	31.3.21 £ - 15,800 699 499 31,022 8,754 1,924 15 - 111 312 - 183 105	£ 16,499 - 16,499 31,248 47,747 42,925 4,822	31.3.20 £ 15,463 19,900 - 554 33,640 8,370 1,668 2,874 617 438 24 100 (855) 105	£ 35,363 320 35,043 - 35,043 47,535 (12,492)

This page does not form part of the statutory financial statements

Page 7